Author:
Jampala Nannaya,Jain Animesh,Herfarth Hans H.,Long Millie D.,Weaver Kimberly N.,Barnes Edward L.
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,Physiology
Reference15 articles.
1. Barnes EL, Jiang Y, Kappelman MD et al. Decreasing Colectomy Rate for Ulcerative Colitis in the United States between 2007 and 2016: A Time Trend Analysis. Inflamm Bowel Dis 2020;26:1225–1231.
2. Argollo M, Kotze PG, Kakkadasam P et al. Optimizing biologic therapy in IBD: how essential is therapeutic drug monitoring? Nat Rev Gastroenterol Hepatol 2020;17:702–710.
3. Denson LA, Curran M, McGovern DPB et al. Challenges in IBD Research: Precision Medicine. Inflamm Bowel Dis 2019;25:S31-s39.
4. Sazonovs A, Kennedy NA, Moutsianas L et al. HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease. Gastroenterology 2020;158:189–199.
5. Suris Marin G, Santacana E, Padullés N et al. P264 Impact of the HLA-DQ1*05 alelle on the initial response to infliximab in patients with Inflammatory Bowel Disease. Journal of Crohn’s and Colitis 2021;15:S301–S302.